|RxNews Recap for Tuesday 01-05-10|
|By Mary Davila|
|Tuesday, 05 January 2010 19:02|
Biotech investors interested in seeing more details about these companies and a full list of their related stories can do so by typing the stock ticker symbol into the Stock Quotes box on the right side of the page.
Applied NeuroSolutions, Inc. (OTCBB: APSN) (www.AppliedNeuroSolutions.com), a biotechnology company focused on the development of products for the early diagnosis and treatment of Alzheimer's disease ("AD"), today announced that Craig S. Taylor, Ph.D., its President and Chief Executive Officer, will present an overview of the Company at the OneMedPlace Finance Forum.
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has an exclusive interview with Matthew L. Schissler, the CEO of Cord Blood America (OTCBB: CBAI), the small cap company that is preparing to open its seventeen thousand square foot state-of-the-art stem cell storage facility and laboratory in Las Vegas.
Biogen Idec Inc. (NASDAQ: BIIB) announced today that its presentation at the 28th Annual J.P. Morgan Healthcare Conference will be webcast live, via the internet, on Tuesday, January 12, 2010 at 4:30 p.m. PST, 7:30 p.m. EST.
Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the fourth quarter and full year of 2009 on Thursday, January 28. During a 10:30 a.m. (ET) conference call on January 28, company executives will review financial information and will address inquiries from investors and analysts.
deCODE genetics, Inc. (Nasdaq:DCGN) today announced that it has received notice from the Nasdaq Stock Market that the company's common stock will be suspended from the Nasdaq Stock Market as of the open of business on January 6, 2010 and a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove deCODE's common stock from listing on Nasdaq.
Graymark Healthcare, Inc. (Nasdaq: GRMH) today announced the addition of Steven L. List to its Board of Directors.
Illumina, Inc. (NASDAQ:ILMN) announced today that the company will webcast its presentation at the J.P. Morgan Healthcare Conference in San Francisco, California, on January 12, 2010.
Dr. Anthony Tolcher, clinical director for South Texas Accelerated Research Therapeutics (START) at the START Center for Cancer Care in San Antonio, announced today that the first patient has been enrolled in a groundbreaking Phase I clinical trial of a novel combination anticancer regimen composed of two investigational compounds: MK-2206 from Merck & Co., Inc. (NYSE:MRK) and AZD6244 (ARRY-886*) from AstraZeneca (NYSE:AZN).
Health Sciences Group, Inc. (PINKSHEETS:HESG) would like to announce that it has engaged in negotiations with The Healing Center to assist with the acquisition of a Medical Marijuana license in the State of Colorado.
King Pharmaceuticals, Inc. (NYSE:KG) today announced plans to provide a live webcast of its presentation scheduled for Wednesday, January 13, 2010, at 2:30 pm Pacific Standard Time, at the J.P. Morgan 28th Annual Healthcare Conference at the Westin St. Francis Hotel in San Francisco, California.
Link Resources, Inc. (OTCBB: LNKR) announced today the completion of a share exchange transaction and concurrent US$12 million private placement pursuant to which it acquired the parent company of Yantai Bohai Pharmaceuticals Group Co., Ltd. (“Bohai”).
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) announced today that on Dec. 31, 2009, it granted options to purchase a total of 5,000 shares of MiddleBrook's common stock to two (2) new employees as a material inducement for them to join MiddleBrook.
Novadel Pharma, Inc. (the “Company”) (OTCBB: NVDL) announces it has entered into an amendment agreement with ProQuest Investments L.P. and its affillates (collectively, “ProQuest”) to convert the outstanding aggregate principal balance of all convertible notes and all liquidated damages notes, in each case, plus all accrued interest, in an aggregate amount equal to $3,657,000 to 23,237,083 shares of the Company’s common stock as of December 31, 2009.
Pall Corporation (NYSE: PLL) announced today that it will present at J.P. Morgan's 28th Annual Healthcare Conference in San Francisco, California on Wednesday, January 13, 2009 at 10:30 AM Pacific Time (1:30 pm ET). Representing the Company will be Eric Krasnoff, Chairman and CEO; and Lisa McDermott, CFO.
PharmAthene, Inc. (NYSE Amex: PIP) a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, today commented on a Special Notice published by the US Department of Health and Human Services (DHHS), Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority (BARDA) on December 29, 2009.
Medidata Solutions (NASDAQ: MDSO), a leading global provider of hosted clinical development solutions, today announced that Glen de Vries, president, and Bruce Dalziel, chief financial officer, will present at the 12th Annual Needham Growth Conference at 10:00 a.m. ET on January 12, 2010 in New York, N.Y.